Troy– Author –
-
Perovskite-Silicon Tandem Commercialization Key to N-Type Solar Module Market Growth; LONGi Initiates Pilot Production
SolarQuarter International Overview The commercialization of perovskite-silicon tandem cells is identified as the most critical long-term development for the N-type solar module market. LONGi achieved a 33.9% efficiency record for perovs... -
GCL Perovskite to Begin Mass Shipment of Commercial Modules by Q3 2026 from 500 MW Line, Achieves 27% Efficiency on Large-Area Tandem
TaiyangNews (YouTube) China Overview GCL Perovskite announced at SNEC 2026 that it will commence commercial shipments of its perovskite modules by the end of Q3 2026, leveraging its operational 500 MW production line. The company has ach... -
JinkoSolar Achieves 34.82% World Record Efficiency for N-Type TOPCon Perovskite Tandem Solar Cell
SolarQuarter China Overview JinkoSolar has announced a new world record of 34.82% power conversion efficiency for its self-developed N-type TOPCon perovskite tandem solar cell, independently certified by the Shanghai Institute of Microsy... -
Oxford PV and Fraunhofer ISE Unveil 25.6% Efficient Perovskite-Silicon Tandem Module with Matrix Shingle Technology
PV Tech Germany Overview Oxford PV and Fraunhofer ISE have jointly announced a new perovskite-silicon tandem module prototype, integrating Oxford PV's high-efficiency tandem cells with Fraunhofer's Matrix Shingle interconnection technolo... -
Health Outcomes Data from Wearables Pivotal for Medicare Coverage Expansion
Forbes USA Overview Health outcomes data derived from wearable devices are proving crucial for expanding Medicare coverage in the United States. Researchers are actively studying the clinical and cost-effectiveness of various wearable te... -
SEMI Smart MedTech Initiative Identifies Key Obstacles and Opportunities for Scaling Wearable Biosensors into Clinical Use
SEMI USA Overview The SEMI Smart MedTech Initiative has published a paper detailing the challenges and opportunities in scaling wearable biosensors from wellness tracking to clinical applications. Despite advancements in semiconductor te... -
Wearable Sensors Underutilized in Clinical Research, Holding Key to Efficiency and Cost Reduction
Clinical Trials Arena UK Overview Despite their potential, wearable sensors remain largely underutilized in pharmaceutical clinical trials, according to Dudley Tabakin, CEO of VivoSense, at the OCT UK & Ireland 2026 conference. He em... -
FDA Reclassifies SARS-CoV-2 POCT Devices to Class II, Easing Regulatory Burden for Rapid Diagnostics
GovInfo (Federal Register) USA Overview The U.S. FDA has issued a final rule, effective June 11, 2026, reclassifying simple point-of-care (POCT) devices for direct detection of SARS-CoV-2 viral targets to Class II (special controls). Thi... -
Continuous Glucose Monitoring (CGM) Study Reveals Correlation Between Glycemic Variability and Headache Intensity in Chronic Migraine Patients
Ethnobotany Research and Applications Unknown Overview A continuous glucose monitoring (CGM) study on chronic migraine patients revealed that participants experienced significant postprandial glycemic variability during waking hours, and... -
Wearable Device ‘Disappearing Act’ Accelerates as Dexcom’s Latest CGM Shrinks by 50%
ZDNET USA Overview Wearable devices are evolving towards 'invisible' designs to integrate more naturally into users' lifestyles, aiming to minimize their presence and enable more consistent wear, thereby enhancing user experience. Dexcom...
